abstract |
The invention concerns compounds of formula (I) (see formula I) wherein W can represent a -(CH2)2-, -(CH2)-C.ident.C- or -CH2-CH=CH- group; R2 can in particular represent a piperidinyl group, a 1,2,3,6-tetrahydropyridinyl group optionally substituted, a hexahydro-1H-azepinyl group, a piperazinyl group optionally substituted or a morphinopolinyl group; R3 can represent a -COR1 group; A can in particular represent a phenyl group optionally substituted, a heterocycle or a cyclopentyl group and B can in particular represent a pyridyl group, an aminopyrazinyl group, an aminopyridazinyl group, a pyrimidinyl group optionally substituted by an amino group, a piperidinyl group or an aminopyridinyl group optionally substituted on the pyridine by a (C1-C4) alkyl or (C1-C4) alkoxy group, the amino group capable of being optionally substituted by a (C1-C4) alkyl group. The invention also concerns the preparation of said compounds and their therapeutic use. |